BioXcel Therapeutics, Inc. Prepaid Expense and Other Assets, Current
BioXcel Therapeutics, Inc. (BTAI) had Prepaid Expense and Other Assets, Current of $3.07 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $3.07M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $3.94M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $4.03M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $5.69M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.07M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.94M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $4.03M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $5.69M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $5.15M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $4.74M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $5.29M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $4.48M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.77M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $2.10M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.78M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $3.85M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.70M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $4.51M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $3.07M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $5.51M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $8.38M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.97M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $2.89M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $4.02M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.60M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $2.77M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $2.96M 10-K · filed 2022-03-11 | $3.95M 10-K · filed 2021-03-12 |
| 2020-09-30 | $2.71M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.82M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $3.52M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $1.68M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $1.11M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.50M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.78M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $491.00K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $467.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $669.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $808.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $3.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |